How did PAHC's operating expenses trend impact its Q2 2025 profitability?

Phibro Animal Health Corporation's (PAHC) operating expenses did not significantly impact its Q2 2025 profitability as the company reported a net income of $3.19 million and total revenue of $309.26 million for the quarter. |code|Ticker|Name|Date|Total Revenue|Net Income|market_code| |---|---|---|---|---|---|---| |PAHC|PAHC.O|Phibro Animal Health|2024 Q3|2.63223E8|8405000|185| |PAHC|PAHC.O|Phibro Animal Health|2024 Q4|2.73164E8|752000|185| |PAHC|PAHC.O|Phibro Animal Health|2025 Q1|2.60432E8|6975000|185| |PAHC|PAHC.O|Phibro Animal Health|2025 Q2|3.09261E8|3185000|185| However, the company's Q3 2025 financial results showed a stronger profitability with a net income of $20.9 million and adjusted EBITDA increasing by 85% to $54.9 million. This indicates that any operating expense management initiatives implemented by PAHC during Q3 2025 contributed positively to the company's profitability.